Skip to content

Perioperative pectoral nerve block type II and postoperative recurrence in breast cancer: a randomized controlled trial

Application of ultrasound-guided type II thoracic nerve block in accelerated rehabilitation surgery for breast cancer surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043039
Enrollment
Unknown
Registered
2021-02-04
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

General Group:General anesthesia
General+PECS-2 Group:general anesthesia with Pecs II block

Sponsors

Department of Anesthesiology, Cangzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 85 Years

Inclusion criteria

Inclusion criteria: BMI 18.5~24.0 kg/m2, ASA grade I-III, no chronic pain, history of abdominal surgery, nerve block contraindications, no abnormal blood coagulation function.

Exclusion criteria

Exclusion criteria: These exclusion criteria involved aged < 18 years, history of other cancer, history of previous surgery, respiratory disease, heart disease, drug allergic in surgery, having chemotherapy or radiotherapy in recent 8 weeks, usage of steroids or opioids, and alcohol dependence.

Design outcomes

Primary

MeasureTime frame
Survival without distant recurrence;Recurrence-free survival;Overall survival;

Secondary

MeasureTime frame
VAS score;Respiratory function;Number of analgesic pump compressions within 48 hours;Nausea and vomiting score;Restlessness during recovery;Postoperative delirium (POD) situation;24 h postoperative recovery quality score;Patient satisfaction;Hospital stay;Nerve Block Adverse Reaction;Incidence of neuropathic pain;Quality of life scale score;

Countries

China

Contacts

Public ContactCui xiuling

Department of Anesthesiology, Cangzhou Central Hospital

Zhangbo19970418@163.com+86 15103172870

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026